The Valley Desk

Clinical trial reportThe Journal of experimental medicinePublished

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer

12 of 40 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of experimental medicine
Published
Subject terms
CD8-Positive T-Lymphocytes; Humans; Neoplasms; Neoplasm Metastasis; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Male; Tumor Microenvironment; Ipilimumab
PubMed ID
39190534
PubMed Central ID
PMC11349049
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal